<DOC>
	<DOC>NCT02458287</DOC>
	<brief_summary>This study is a multicenter, randomized study in subjects with high cholesterol receiving statins to assess the efficacy to lower LDL-C, the safety, tolerability and actual use of bococizumab and an autoinjector (pre-filled pen).</brief_summary>
	<brief_title>Efficacy, Safety, Tolerability And Actual Use Study Of Bococizumab And An Autoinjector (Pre-Filled Pen) In Subjects With Hyperlipidemia Or Dyslipidemia</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<criteria>Treated with a statin Fasting LDLC &gt;=70mg/dL and triglycerides &lt;=400mg/dL Pregnant or breastfeeding females Cardiovascular or cerebrovascular event or procedures during the past 90 days Congestive heart failure NYHA class IV Poorly controlled hypertension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>mixed dyslipidemia</keyword>
</DOC>